Seoul Medical Group and Renaissance Imaging: The Reports Behind the Spinal Diagnoses

In the Seoul Medical Group and Renaissance Imaging False Claims Act settlement, the provider, its former owner and the imaging group agreed to pay over $62 million to resolve allegations of Medicare Advantage risk adjustment fraud involving spinal diagnoses. The government alleged that patients did not have the conditions being reported, and that a radiology practice helped produce supporting reports when a health plan questioned one diagnosis. If you work with diagnosis codes, imaging reports or provider payments, that sequence is worth a closer look.

The Justice Department announced the civil settlement on March 26, 2025. Advanced Medical Management, Seoul Medical Group’s subsidiary, was also part of the settlement. Renaissance Imaging Medical Associates was a separate California radiology group that worked with the provider.

How a Spinal Diagnosis Increased Medicare Advantage Payments

The government alleged that Seoul Medical Group submitted spinal enthesopathy and sacroiliitis diagnoses from 2015 through 2021 for patients who did not have those conditions. The government alleged that both diagnoses increased payments from Medicare to the health plan, which passed a portion of the increase to Seoul Medical Group.

Medicare adjusts its payments using demographic information and diagnoses for each beneficiary. Diagnoses associated with more expensive treatment generally produce a higher risk score and a larger payment to the plan.

Here, according to the government’s account, the provider shared in the additional money generated by the disputed diagnoses. The incentive reached the organization supplying the diagnosis data.

This is why a claim involving government money can reach beyond a bill sent directly to Medicare. The False Claims Act reaches a company that causes a false claim to be submitted as well as one that submits it. In a case like this, we follow the diagnosis through the health plan and into the payment it generated. The provider’s data and the plan’s payment records tell connected parts of the story.

Radiology Reports After the Health Plan Asked Questions

The government’s allegation against Renaissance concerned reports that appeared to support spinal enthesopathy after a Medicare Advantage plan questioned Seoul Medical Group’s use of that diagnosis. According to the Justice Department, Seoul Medical Group enlisted the imaging group’s assistance to create those reports.

We expect clinical evidence to drive the diagnosis. The government’s account describes the reverse: a questioned diagnosis driving the request for radiology support. Diagnosis first. Evidence later.

Taxpayers were allegedly paying more for conditions the patients did not have, while the provider sought reports that would make one of those conditions look supported.

For an imaging or coding insider, the connection between the report and the submitted diagnosis matters. We examine what the clinical record says, what the radiology report says, how the diagnosis entered the payment data and who requested the supporting documentation. A dated request, the report it produced and the diagnosis submitted to the plan can explain the sequence far more clearly than a payment total.

The evidence connecting the records to the money also tells us where different people fit. The person responsible for a report may know what prompted its wording. Someone handling diagnosis submissions may know how that wording reached the plan. Someone in finance may understand how the plan’s increased payment reached the provider. We work with the insider to connect those views into a case about the underlying decisions.

The Whistleblower Came From the Management Company

A former vice president and chief financial officer of Advanced Medical Management brought the qui tam case resolved by the settlement. The whistleblower came from inside the provider’s subsidiary, close to the business side of the arrangement.

That role matters because the alleged mechanism crossed clinical documentation and money. Finance knowledge can help explain how an increase in plan payment reaches a provider, while coding and clinical knowledge can explain what generated the increase. We look at how those pieces fit together, including what the people handling them knew at the time.

The question of who can bring a whistleblower case starts with what that person knows. For a health care insider with a different job title, the useful conversation is about the part of the diagnosis, documentation or payment process they can explain.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

Separate Agreements for the Provider, Its Former Owner and the Imaging Group

Seoul Medical Group and Advanced Medical Management agreed to pay $58,740,000. The former president and majority owner separately agreed to pay $1,760,000. Renaissance Imaging Medical Associates separately agreed to pay $2,350,000.

Those allocations reflect the distinct roles described in the government’s allegations. Seoul Medical Group and its former president allegedly caused false spinal-diagnosis submissions that increased Medicare Advantage payments. Renaissance’s agreement resolved allegations that it conspired with Seoul Medical Group in connection with those diagnoses. Its alleged contribution was the radiology support.

A report created outside the organization submitting the diagnosis was still part of the government’s account of how the payment claim gained apparent support.

The Same Pressure on Diagnosis Evidence in Other Cases

Other Medicare Advantage cases show how financial incentives can reach the people creating diagnosis evidence. In its complaint against Sutter Health, the government alleged that Sutter and Palo Alto Medical Foundation pursued more risk-adjusting diagnosis codes regardless of whether they matched patients’ documented conditions. The complaint placed the origin of that effort inside management:

In Seoul’s case, the government’s account adds an outside imaging practice to that connection. The people who know why a report was requested may see something that a reviewer of the final diagnosis data cannot.

The government’s complaint against Cigna alleged a different route to unsupported diagnoses. It said home-visit providers lacked equipment needed for testing or imaging, and Cigna did not permit them to order the necessary tests or make referrals to providers who would. The complaint also alleged that Cigna tracked the diagnoses produced by vendors and their effect on risk-adjusted payments.

These allegations put a practical question in front of anyone who works with diagnosis evidence: what actually supported the condition reported for payment? In Cigna’s case, the government challenged diagnoses made without necessary testing or imaging. In Seoul’s, it challenged the use of radiology reports to support a questioned diagnosis. We connect that clinical account to the people requesting the documentation and the money the diagnosis generated.

You Know Why the Report Was Requested

If you know who asked for a diagnosis, what the imaging report supported or how the provider was paid, talk with our whistleblower experts about what you saw. We build the case with you and bring in Medicare Advantage fraud whistleblower lawyers who understand risk adjustment and clinical documentation. From the first account of a questioned report through the pursuit of a recovery, we stay on your side of the table.